Fineotex Chemical Limited has informed the Exchange regarding Appointment of HSPN Associates LLP as Secretarial Auditor of the company for the first term of five (5) consecutive years for the financial year 2025-2026 to 2029-30 w.e.f. August 12, 2025
FCL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Fineotex Chemical's board, which met on August 12, 2025, approved its Q1 FY26 financial results showing strong consolidated growth. Revenue rose about 14.4% quarter-on-quarter to Rs. 137.07 crore, profit after tax jumped 24.3% to Rs. 25.03 crore, and operational EBITDA grew 18.4% to Rs. 25.20 crore. On a standalone basis, revenue was Rs. 98.26 crore with PAT of Rs. 19.89 crore. The company also announced the commissioning of a new manufacturing facility at Ambernath adding 3 lakh sq. ft. of capacity. M/s HSPN & Associates LLP was appointed as Secretarial Auditor for an initial five-year term, and Mr. Chetan Shah was appointed as an Additional Independent Director for five years. Additionally, 58,797 stock options were granted to eligible employees under the FCL-ESOP 2020 plan. The 22nd Annual General Meeting is scheduled for September 19, 2025.
Positive quarter with double-digit revenue and profit growth, a new production facility coming online, and solid 30%+ ROIC signals strong operational momentum. The new auditor and independent director appointments are routine governance steps, while the ESOP grant is a small, non-dilutive reward for employees. Overall, this is a healthy operational update with no negative governance signals for shareholders.